Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,533 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Resistance to antiangiogenic therapy.
Weathers SP, de Groot J. Weathers SP, et al. Among authors: de groot j. Curr Neurol Neurosci Rep. 2014 May;14(5):443. doi: 10.1007/s11910-014-0443-y. Curr Neurol Neurosci Rep. 2014. PMID: 24652451 Review.
VEGF Manipulation in Glioblastoma.
Weathers SP, de Groot J. Weathers SP, et al. Among authors: de groot j. Oncology (Williston Park). 2015 Oct;29(10):720-7. Oncology (Williston Park). 2015. PMID: 26470893 Free article. Review.
Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies.
Garber ST, Hashimoto Y, Weathers SP, Xiu J, Gatalica Z, Verhaak RG, Zhou S, Fuller GN, Khasraw M, de Groot J, Reddy SK, Spetzler D, Heimberger AB. Garber ST, et al. Among authors: de groot j. Neuro Oncol. 2016 Oct;18(10):1357-66. doi: 10.1093/neuonc/now132. Epub 2016 Jul 1. Neuro Oncol. 2016. PMID: 27370400 Free PMC article.
Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages.
de Groot J, Penas-Prado M, Alfaro-Munoz K, Hunter K, Pei BL, O'Brien B, Weathers SP, Loghin M, Kamiya Matsouka C, Yung WKA, Mandel J, Wu J, Yuan Y, Zhou S, Fuller GN, Huse J, Rao G, Weinberg JS, Prabhu SS, McCutcheon IE, Lang FF, Ferguson SD, Sawaya R, Colen R, Yadav SS, Blando J, Vence L, Allison J, Sharma P, Heimberger AB. de Groot J, et al. Neuro Oncol. 2020 Apr 15;22(4):539-549. doi: 10.1093/neuonc/noz185. Neuro Oncol. 2020. PMID: 31755915 Free PMC article.
Pre-surgical connectome features predict IDH status in diffuse gliomas.
Kesler SR, Harrison RA, Petersen ML, Rao V, Dyson H, Alfaro-Munoz K, Weathers SP, de Groot J. Kesler SR, et al. Among authors: de groot j. Oncotarget. 2019 Nov 5;10(60):6484-6493. doi: 10.18632/oncotarget.27301. eCollection 2019 Nov 5. Oncotarget. 2019. PMID: 31741712 Free PMC article.
Results of a phase I trial to assess the safety of macitentan in combination with temozolomide for the treatment of recurrent glioblastoma.
Weathers SP, Rood-Breithaupt J, de Groot J, Thomas G, Manfrini M, Penas-Prado M, Puduvalli VK, Zwingelstein C, Yung WKA. Weathers SP, et al. Among authors: de groot j. Neurooncol Adv. 2021 Oct 2;3(1):vdab141. doi: 10.1093/noajnl/vdab141. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 34693288 Free PMC article.
1,533 results